Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 340

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: JM%5BAuthor%5D.

Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions.

Burkhalter JE, Atkinson TM, Berry-Lawhorn J, Goldstone S, Einstein MH, Wilkin TJ, Lee J, Cella D, Palefsky JM; ANCHOR HRQOL Implementation Group.

Value Health. 2018 Aug;21(8):984-992. doi: 10.1016/j.jval.2018.01.018. Epub 2018 Apr 11.


A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in HIV-infected adults: An AIDS Malignancy Consortium trial.

Goldstone SE, Lensing SY, Stier EA, Darragh T, Lee JY, van Zante A, Jay N, Berry-Lawhorn JM, Cranston RD, Mitsuyasu R, Aboulafia D, Palefsky JM, Wilkin T.

Clin Infect Dis. 2018 Jul 27. doi: 10.1093/cid/ciy615. [Epub ahead of print]


Erratum: E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Wechsler EI, Tugizov S, Herrera R, Costa MD, Palefsky JM.

J Gen Virol. 2018 Jul;99(7):948. doi: 10.1099/jgv.0.001084. No abstract available.


A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men.

Ellsworth GB, Lensing SY, Ogilvie CB, Lee JY, Goldstone SE, Berry-Lawhorn JM, Jay N, Stier EA, Logan JS, Einstein MH, Saah A, Mitsuyasu RT, Aboulafia D, Palefsky JM, Wilkin TJ.

Papillomavirus Res. 2018 May 26;6:11-14. doi: 10.1016/j.pvr.2018.05.001. [Epub ahead of print] No abstract available.


Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.

Mudini W, Palefsky JM, Hale MJ, Chirenje MZ, Makunike-Mutasa R, Mutisi F, Murahwa A, Mario A.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):e1-e6. doi: 10.1097/QAI.0000000000001754.


Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.

Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):10-19. doi: 10.1097/QAI.0000000000001727.


High pregnancy incidence and low contraceptive use among a prospective cohort of female entertainment and sex workers in Phnom Penh, Cambodia.

Duff P, Evans JL, Stein ES, Page K, Maher L; Young Women’s Health Study Collaborative.

BMC Pregnancy Childbirth. 2018 May 3;18(1):128. doi: 10.1186/s12884-018-1768-3.


E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Wechsler EI, Tugizov S, Herrera R, Da Costa M, Palefsky JM.

J Gen Virol. 2018 May;99(5):631-644. doi: 10.1099/jgv.0.001061. Epub 2018 Apr 6.


Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth.

Sohn AH, Kerr SJ, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Chalermchockcharoenkit A, Thamkhantho M, Pankam T, Singtoroj T, Termrungruanglert W, Chaithongwongwatthana S, Phanuphak N; HPV in Adolescents Study .

Clin Infect Dis. 2018 Mar 30. doi: 10.1093/cid/ciy144. [Epub ahead of print]


Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.

Ortiz AP, Tortolero-Luna G, Romaguera J, Pérez CM, González D, Muñoz C, González L, Marrero E, Suárez E, Palefsky JM, Panicker G, Unger ER.

Papillomavirus Res. 2018 Jun;5:109-113. doi: 10.1016/j.pvr.2018.03.006. Epub 2018 Mar 16.


Periodontitis and oral human papillomavirus infection among Hispanic adults.

Ortiz AP, González D, Vivaldi-Oliver J, Castañeda M, Rivera V, Díaz E, Centeno H, Muñoz C, Palefsky J, Joshipura K, Pérez CM.

Papillomavirus Res. 2018 Jun;5:128-133. doi: 10.1016/j.pvr.2018.03.003. Epub 2018 Mar 16.


Prevalence of and risk factors for anal high-risk HPV among HIV-negative and HIV-positive MSM and transgender women in three countries at South-East Asia.

Somia IKA, Teeratakulpisarn N, Jeo WS, Yee IA, Pankam T, Nonenoy S, Trachuntong D, Mingkwanrungrueng P, Sukmawati MDD, Ramautarsing R, Nilasari H, Hairunisa N, Azwa I, Yunihastuti E, Merati TP, Phanuphak P, Palefsky J, Phanuphak N; ANSAP Study Group.

Medicine (Baltimore). 2018 Mar;97(10):e9898. doi: 10.1097/MD.0000000000009898.


IPVS statement moving towards elimination of cervical cancer as a public health problem.

Garland SM, Giuliano A, Brotherton J, Moscicki AB, Stanley M, Kaufmann AM, Bhatla N, Sankaranarayanan R, Palefsky JM, de Sanjose S; IPVS.

Papillomavirus Res. 2018 Jun;5:87-88. doi: 10.1016/j.pvr.2018.02.003. Epub 2018 Feb 27. No abstract available.


Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.

Kojic EM, Conley L, Bush T, Cu-Uvin S, Unger ER, Henry K, Hammer J, Escota G, Darragh TM, Palefsky JM, Brooks JT, Patel P.

J Infect Dis. 2018 Apr 23;217(10):1544-1552. doi: 10.1093/infdis/jiy087.


CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.

Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA.

Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245. Epub 2018 Feb 15.


The Cape Town declaration on human papillomavirus related disease.

Williamson AL, Garland S, Palefsky J, Rybicki E, Stanley M, de Sanjosé S.

Papillomavirus Res. 2018 Jun;5:59-60. doi: 10.1016/j.pvr.2017.12.003. Epub 2017 Dec 30. No abstract available.


Prevalence, Incidence, and Clearance of Anal High-Risk Human Papillomavirus Infection Among HIV-Infected Men in the SUN Study.

Patel P, Bush T, Kojic EM, Conley L, Unger ER, Darragh TM, Henry K, Hammer J, Escota G, Palefsky JM, Brooks JT.

J Infect Dis. 2018 Mar 5;217(6):953-963. doi: 10.1093/infdis/jix607.


HPV vaccination of immunocompromised hosts.

Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, Sankaranarayanan R, de Sanjosé S, Palefsky JM; IPVS.

Papillomavirus Res. 2017 Dec;4:35-38. doi: 10.1016/j.pvr.2017.06.002. Epub 2017 Jun 3.


Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.

Ortiz AP, Romaguera J, Pérez CM, González D, Muñoz C, González L, Marrero E, Tortolero-Luna G, Suárez E, Palefsky J.

Papillomavirus Res. 2016 Dec;2:89-96. doi: 10.1016/j.pvr.2016.04.002. Epub 2016 Apr 26.

Supplemental Content

Loading ...
Support Center